Impaired calcium handling mechanisms in atrial trabeculae of diabetic patients

Timothy L M Jones1, Sarbjot Kaur1, Nicholas Kang2

  • 1Department of Physiology, University of Auckland, Auckland, New Zealand.

Physiological Reports
|February 7, 2023
PubMed

Insights

Diabetic patients show impaired cardiomyocyte calcium handling and contractile dysfunction in atrial tissue. This dysfunction involves altered calcium transients and reduced myofilament calcium sensitivity, impacting heart function.

Area of Science:

  • Cardiology
  • Physiology
  • Biochemistry

Background:

  • Type 2 diabetes is associated with cardiovascular complications.
  • Diabetic cardiomyopathy affects cardiac structure and function.
  • Alterations in cardiomyocyte calcium handling are implicated in diabetic heart disease.

Purpose of the Study:

  • To investigate cardiomyocyte calcium (Ca2+) handling and contractile function in human atrial tissue from diabetic and non-diabetic patients.
  • To compare Ca2+ transients, myofilament Ca2+ sensitivity, and developed force between groups.
  • To elucidate the impact of diabetes on atrial electro-mechanical coupling.

Main Methods:

  • Dissection of multicellular atrial trabeculae from diabetic and non-diabetic patients.
  • Measurement of intracellular Ca2+ using fura-2/AM during electrical stimulation.
  • Assessment of myofilament Ca2+ sensitivity via phase plots and high potassium contractures.

Main Results:

  • Diabetic trabeculae exhibited increased diastolic Ca2+ and reduced Ca2+ transient amplitude.
  • Peak developed stress was decreased, and diastolic stress was increased in diabetic trabeculae.
  • Myofilament Ca2+ sensitivity was diminished in atrial tissue from diabetic patients.

Conclusions:

  • Diabetes impairs cardiomyocyte Ca2+ handling and leads to contractile dysfunction in human atrial tissue.
  • Altered Ca2+ homeostasis and reduced myofilament Ca2+ sensitivity contribute to diabetic cardiomyopathy.
  • Targeting cardiomyocyte Ca2+ handling may offer future therapeutic strategies for diabetic heart disease.

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.0K
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
70
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
924
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
15
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
21
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
629